These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11576767)

  • 1. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol.
    Agarwal R; Katare OP; Vyas SP
    Int J Pharm; 2001 Oct; 228(1-2):43-52. PubMed ID: 11576767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novelliposomal formulation of dithranol for psoriasis: preliminary results.
    Agarwal R; Saraswat A; Kaur I; Katare OP; Kumar B
    J Dermatol; 2002 Aug; 29(8):529-32. PubMed ID: 12227489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
    Ning M; Gu Z; Pan H; Yu H; Xiao K
    Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo-in vivo evaluation study.
    Abu Hashim II; Abo El-Magd NF; El-Sheakh AR; Hamed MF; Abd El-Gawad AEH
    Int J Nanomedicine; 2018; 13():1059-1079. PubMed ID: 29503541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
    Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG
    Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining.
    Lau WM; White AW; Heard CM
    Pharm Res; 2010 Dec; 27(12):2734-42. PubMed ID: 20872052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of topical corticosteroids and a coal tar preparation on dithranol-induced irritation in patients with psoriasis.
    Swinkels OQ; Kucharekova M; Prins M; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(1):12-7. PubMed ID: 12566824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
    Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
    J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of dithranol in topical formulations.
    Thoma K; Holzmann C
    Acta Pharm Hung; 1998 Nov; 68(6):313-21. PubMed ID: 9987194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a topical niosomal preparation of acetazolamide: preparation and evaluation.
    Aggarwal D; Garg A; Kaur IP
    J Pharm Pharmacol; 2004 Dec; 56(12):1509-17. PubMed ID: 15563757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
    Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
    J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.